Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
PURPOSE: To assess the frequency of expression and the prognostic significance of a hypoxia-regulated marker, carbonic anhydrase IX (CA IX), in a cohort of patients with invasive breast cancer. PATIENTS AND METHODS: CA IX expression was evaluated by immunohistochemistry with a murine monoclonal antibody, M75, in a series of 103 women treated surgically for invasive breast cancer. The majority of patients were treated with adjuvant hormonal or chemotherapy. The frequency of CA IX expression, its association with recognized prognostic factors, and the relationship with outcome was evaluated by univariate and multivariate statistical analyses. RESULTS: CA IX expression was present in 49 (48%) of 103 cases. The level of CA IX expression was found to be significantly associated with tumor necrosis (P < .001), higher grade (P = .02), and negative estrogen receptor status (P < .001). Furthermore, CA IX expression was associated with a higher relapse rate (P = .004) and a worse overall survival (P = .001). By multivariate analysis, CA IX was also shown to be an independent predictive factor for overall survival (hazard ratio, 2.61; 95% confidence interval, 1.01 to 6.75, P = .05). CONCLUSION: CA IX expression was associated with worse relapse-free survival and overall survival in an unselected cohort of patients with invasive breast carcinoma. The potential role of CA IX as a marker of hypoxia within breast carcinomas was also indicated by a significant association with necrosis. Further work assessing its prognostic significance in breast cancer is warranted, particularly interactions with radiotherapy and chemotherapy resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,926
Carbonic anhydrase: chemistry, physiology, and inhibition
Maren, T. H. (1967) · Physiological Reviews · doi:10.1152/physrev.1967.47.4.595 · Cited by 1,889
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,489
Self-citation(1996) · PubMed · Cited by 1,141
Fisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B., Foster, R., Gardner, B., Lerner, H., Margolese, R., et al. (1983) · Cancer · doi:10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3 · Cited by 1,034
Nordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942
Cited by
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Self-citationHypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Lou, Y., McDonald, P. C., Oloumi, A., Chia, S., Ostlund, C., Ahmadi, A., Kyle, A., auf dem Keller, U., Leung, S., Huntsman, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4261 · Cited by 755
Self-citationTumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Chiche, J., Brahimi‐Horn, M. C., & Pouysségur, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00994.x · Cited by 667
Chi, J.-T., Wang, Z., Nuyten, D. S. A., Rodriguez, E. H., Schaner, M. E., Salim, A., Wang, Y., Kristensen, G. B., Helland, Å., Børresen-Dale, A.-L., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030047 · Cited by 619
Regulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539
“associated with the oestrogen receptor-negative phenotype [74] and tumors resistant to epirubicin [79].”
BackgroundSelf-citationPacchiano, F., Carta, F., McDonald, P. C., Lou, Y., Vullo, D., Scozzafava, A., Dedhar, S., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101541x · Cited by 519
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500
Hypoxic gene expression and metastasis
Le, Q.-T., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 468
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
McDonald, P. C., Winum, J.-Y., Supuran, C. T., & Dedhar, S. (2012) · Oncotarget · doi:10.18632/oncotarget.422 · Cited by 421
Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5378 · Cited by 420
HIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Self-citationSchneider, B. P., & Miller, K. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.017 · Cited by 350
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
Pastorek, J., & Pastorekova, S. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.08.002 · Cited by 328
Self-citationRole of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion
Robertson, N., Potter, C., & Harris, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2224 · Cited by 304
Self-citationCarbonic anhydrase IX in oligodendroglial brain tumors
Järvelä, S., Parkkila, S., Bragge, H., Kähkönen, M., Parkkila, A.-K., Soini, Y., Pastorekova, S., Pastorek, J., & Haapasalo, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-1 · Cited by 291
Self-citationSwinson, D. E. B., Jones, J. L., Richardson, D., Wykoff, C., Turley, H., Pastorek, J., Taub, N., Harris, A. L., & O’Byrne, K. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.132 · Cited by 287
Self-citationBussink, J., Kaanders, J. H. A. M., & van der Kogel, A. J. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00011-2 · Cited by 276
Prognostic significance of tumor oxygenation in humans
Evans, S. M., & Koch, C. J. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00012-0 · Cited by 259
Applications of carbonic anhydrase inhibitors and activators in therapy
Supuran, C. T., & Scozzafava, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.2.217 · Cited by 258
Touisni, N., Maresca, A., McDonald, P. C., Lou, Y., Scozzafava, A., Dedhar, S., Winum, J.-Y., & Supuran, C. T. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200983e · Cited by 253
uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
Lester, R. D., Jo, M., Montel, V., Takimoto, S., & Gonias, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701092 · Cited by 253
Supuran, C. T., Alterio, V., Di Fiore, A., D’ Ambrosio, K., Carta, F., Monti, S. M., & De Simone, G. (2018) · Medicinal Research Reviews · doi:10.1002/med.21497 · Cited by 253
McIntyre, A., Patiar, S., Wigfield, S., Li, J.-L., Ledaki, I., Turley, H., Leek, R., Snell, C., Gatter, K., Sly, W. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1877 · Cited by 239
Self-citationNew insights into the physiological role of carbonic anhydrase IX in tumour pH regulation
Swietach, P., Hulikova, A., Vaughan-Jones, R. D., & Harris, A. L. (2010) · Oncogene · doi:10.1038/onc.2010.455 · Cited by 233
“, 1997) express significant levels of CAIX, so that positive staining for CAIX is now an established marker of tumour hypoxia and a clinical indicator of aggressive cancers (for example, breast and bone) with poor prognosis (Chia et al., 2001; Giatromanolaki et al., 2001; Generali et al., 2006).”
InfluentialSelf-citationVleugel, M. M., Greijer, A. E., Shvarts, A., van der Groep, P., van Berkel, M., Aarbodem, Y., van Tinteren, H., Harris, A. L., van Diest, P. J., & van der Wall, E. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.019885 · Cited by 227
Self-citationStessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., Jackson, D. G., Colpaert, C. G., Van Marck, E. A., Dirix, L. Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601727 · Cited by 214
“Immunohistochemical staining for CA9 was performed at the Weatherall Institute of Molecular Medicine (John Radcliffe Hospital, Headington, Oxford, UK) with the murine monoclonal antibody M75 at a dilution of 1 : 50, as has been described before (Chia et al, 2001).”
MethodSelf-citationYasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 198
Molecular mechanisms of hypoxia in cancer
Challapalli, A., Carroll, L., & Aboagye, E. O. (2017) · Clinical and Translational Imaging · doi:10.1007/s40336-017-0231-1 · Cited by 163
The Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132
Hunter, F. W., Young, R. J., Shalev, Z., Vellanki, R. N., Wang, J., Gu, Y., Joshi, N., Sreebhavan, S., Weinreb, I., Goldstein, D. P., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1107 · Cited by 82
“Harris, University of Oxford, Oxford, United Kingdom) as described previously (34).”
BackgroundCooper, C., Liu, G.-Y., Niu, Y.-L., Santos, S., Murphy, L. C., & Watson, P. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1235 · Cited by 64
Self-citationAuslander, N., Yizhak, K., Weinstock, A., Budhu, A., Tang, W., Wang, X. W., Ambs, S., & Ruppin, E. (2016) · Scientific Reports · doi:10.1038/srep29662 · Cited by 50
Metadata
- Authors
- Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., & Harris, A. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-08-15
- Volume
- 19
- Issue
- 16
- Pages
- 3660-3668
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1962692964
- Cited by
- 432
- References
- 38
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.